T. Rowe Price Group

Nuro, Inc. is a technology company established in 2016 and headquartered in Mountain View, California. The company specializes in manufacturing self-driving vehicles specifically designed for local goods transportation. Nuro's autonomous delivery service enhances local commerce by enabling merchants to efficiently deliver a wide range of products, including food and pharmaceuticals, directly to customers. Their fleet of electric, fully autonomous vehicles aims to provide quick, affordable, and safe delivery options, thereby transforming the logistics of local deliveries.

Epirus, Inc. is a company focused on developing advanced defense technologies that utilize artificial intelligence and directed energy systems. Based in Hawthorne, California, it specializes in solid-state, software-defined high-power microwave systems designed to counter unmanned aircraft and other asymmetric threats. The company's flagship product, ELECTROMAGNETIC PULSE, functions as a drone countermeasure by delivering multiple beams simultaneously, effectively disrupting and neutralizing aerial threats. Additionally, Epirus employs AI and computer vision to enhance its capabilities in detecting and tracking various targets of interest. Founded in 2018, Epirus aims to provide innovative solutions for both national security and commercial applications, optimizing power management and efficiency in electronic warfare scenarios.

Outset Medical, Inc. is a medical technology company based in San Jose, California, focused on innovating hemodialysis systems. The company has developed Tablo, a compact dialysis machine designed for use in both acute and chronic care settings. This system integrates essential features such as water purification, on-demand dialysate production, and advanced software capabilities, including wireless data connectivity and sensor-based automation. By simplifying the dialysis process, Tablo aims to reduce costs and enhance the experience for both patients and healthcare providers. Founded in 2003 and originally named Home Dialysis Plus, Ltd., Outset Medical rebranded in 2015 to reflect its commitment to transforming dialysis care.

Sila is a battery materials company founded in 2011 and headquartered in California, United States. It specializes in manufacturing energy-dense lithium-ion batteries designed for electric vehicles and consumer electronics. Sila collaborates with automotive original equipment manufacturers (OEMs) to accelerate product development and partners with battery manufacturers to enhance commercial cell production. The company focuses on providing advanced battery materials that improve energy storage capabilities, enabling the production of small, light, and long-lasting devices. By offering superior performance and quality control, Sila aims to facilitate the mass adoption of affordable, long-range electric vehicles while maintaining safety and cycle life standards.

Endeavor BioMedicines is a clinical-stage company based in Solana Beach, California, that focuses on developing innovative treatments for pulmonary fibrosis, particularly idiopathic pulmonary fibrosis (IPF). Founded in 2018, the company is working on a small-molecule inhibitor designed to target the underlying causes of this progressive lung disease. The treatment aims to not only halt the progression of IPF but also has the potential to reverse its effects, offering healthcare professionals a new avenue for precision treatments in managing terminal conditions. Endeavor BioMedicines strives to improve patient outcomes and enhance quality of life for those affected by this challenging illness.

Freenome, Inc. is a biotechnology company based in South San Francisco, California, founded in 2014. It specializes in developing artificial intelligence-driven genomic solutions for the early detection of cancer. The company focuses on creating simple, non-invasive blood tests that can identify early-stage cancer and assist in treatment selection, thus enabling proactive disease management. Freenome’s multi-omics platform employs proprietary algorithms to enhance disease screening processes, aiming to facilitate timely interventions and improve treatment effectiveness. In addition to its diagnostic products, Freenome also offers clinical research services to support its mission of transforming cancer management through systematic early detection.

Lilac Solutions, Inc. is a mining technology company focused on lithium extraction, providing innovative technology and services to lithium producers. The company specializes in ion exchange beads and continuous brine processing systems, which enable the efficient production of high-purity lithium solutions from various brine resources. This technology, grounded in ion-exchange theory, allows lithium producers to enhance project development, improve lithium recovery rates, and optimize operational efficiency while also minimizing costs and environmental impact. Lilac Solutions serves industries such as electric vehicles and renewable energy storage. Incorporated in 2015, the company is headquartered in Oakland, California.

RefleXion Medical Inc. is a medical equipment company specializing in the development of biologically-guided radiotherapy systems for cancer treatment. Its flagship innovation, the RefleXion X1 machine, is designed to deliver advanced radiation therapies such as stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS). The company's biologically-guided radiotherapy (BgRT) technology utilizes positron-emission tomography (PET) imaging data to allow tumors to continuously signal their location during treatment, enabling the possibility of treating multiple tumors in a single session, especially in cases of metastasized cancers. This real-time adaptation to the biological characteristics of tumors represents a significant advancement in radiation oncology. RefleXion Medical, incorporated in 2009 and based in Hayward, California, has established strategic partnerships with Telix Pharmaceuticals Limited and HealthMyne Inc. to further its mission in cancer treatment innovation.

Databricks Inc. offers a unified data analytics cloud platform that simplifies data engineering and supports collaborative data science. Its core product, Databricks, enables organizations to process and analyze large datasets efficiently, leveraging tools like Apache Spark. The platform is designed for real-time experimentation and robust deployment of production applications, catering to developers and data scientists. Additionally, Databricks provides Databricks Delta, a data management system that combines the scalability of a data warehouse with low-latency streaming capabilities. The company also offers MLflow for managing the machine learning lifecycle and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including healthcare, finance, manufacturing, and telecommunications. Founded in 2013 and headquartered in San Francisco, with additional offices in London, Amsterdam, and Bengaluru, Databricks has established strategic partnerships to enhance its offerings and foster innovation in data and AI technologies.

Genesis Therapeutics Inc. is a biotechnology company based in South San Francisco, California, that focuses on developing small molecule drug candidates aimed at treating patients with severe and debilitating disorders. Established in 2019, the company harnesses a proprietary artificial intelligence platform that employs advanced deep neural networks and biophysical simulation techniques to enhance drug discovery and molecular design. By combining these innovative technologies with a scalable computing infrastructure, Genesis Therapeutics aims to improve the efficiency and accuracy of molecular research. This approach not only facilitates the generation and analysis of novel drug candidates but also holds the potential to significantly advance clinical outcomes in the medical community.

ADARx Pharmaceuticals, Inc. is a clinical-stage biotechnology company based in San Diego, California, focused on the research and development of RNA editing therapeutics. Founded in 2019, the company specializes in the precise targeting and correction of single point mutations on mRNA transcripts using a proprietary platform that leverages endogenous enzymes known as adenosine deaminase acting on RNA (ADAR). This innovative approach aims to restore the production of functional proteins, addressing genetic mutations that lead to various diseases. ADARx Pharmaceuticals is developing a diverse pipeline of ribonucleic acid targeting therapeutics aimed at treating conditions across multiple therapeutic areas, including genetic disorders, cardiometabolic diseases, complement-mediated diseases, and central nervous system disorders.

RefleXion Medical Inc. is a medical equipment company specializing in the development of biologically-guided radiotherapy systems for cancer treatment. Its flagship innovation, the RefleXion X1 machine, is designed to deliver advanced radiation therapies such as stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS). The company's biologically-guided radiotherapy (BgRT) technology utilizes positron-emission tomography (PET) imaging data to allow tumors to continuously signal their location during treatment, enabling the possibility of treating multiple tumors in a single session, especially in cases of metastasized cancers. This real-time adaptation to the biological characteristics of tumors represents a significant advancement in radiation oncology. RefleXion Medical, incorporated in 2009 and based in Hayward, California, has established strategic partnerships with Telix Pharmaceuticals Limited and HealthMyne Inc. to further its mission in cancer treatment innovation.

Rigetti Computing is a full-stack quantum computing company that designs and manufactures quantum-integrated circuits, deploying them in low-temperature environments. The company develops proprietary control systems to execute quantum logic operations and has created software to integrate its quantum systems with existing cloud infrastructure. Rigetti's innovations include the industry's first multi-chip quantum processor, which enables scalability in quantum computing systems. The company focuses on practical applications of quantum computing, particularly in computational chemistry and machine learning, and offers the Forest platform, a comprehensive programming and execution environment for quantum and classical computing. Most of its revenue is generated from the United States.

CelLink Corporation is an innovative company focused on developing flexible conductive backplanes and circuits for power electronics, including applications in batteries, solar panels, light-emitting diodes, and wire harnessing. Founded in 2012 and based in Belmont, California, CelLink manufactures high-conductance, large-area flexible circuits designed to facilitate clean power transmission. Their products integrate essential components such as busing, fusing, and voltage and temperature monitoring into a single circuit, providing customers with efficient solutions for power and data transmission at competitive prices. By offering advanced technology in a growing market, CelLink aims to support the increasing demand for sustainable energy solutions.

Epirus, Inc. is a company focused on developing advanced defense technologies that utilize artificial intelligence and directed energy systems. Based in Hawthorne, California, it specializes in solid-state, software-defined high-power microwave systems designed to counter unmanned aircraft and other asymmetric threats. The company's flagship product, ELECTROMAGNETIC PULSE, functions as a drone countermeasure by delivering multiple beams simultaneously, effectively disrupting and neutralizing aerial threats. Additionally, Epirus employs AI and computer vision to enhance its capabilities in detecting and tracking various targets of interest. Founded in 2018, Epirus aims to provide innovative solutions for both national security and commercial applications, optimizing power management and efficiency in electronic warfare scenarios.

Endeavor BioMedicines is a clinical-stage company based in Solana Beach, California, that focuses on developing innovative treatments for pulmonary fibrosis, particularly idiopathic pulmonary fibrosis (IPF). Founded in 2018, the company is working on a small-molecule inhibitor designed to target the underlying causes of this progressive lung disease. The treatment aims to not only halt the progression of IPF but also has the potential to reverse its effects, offering healthcare professionals a new avenue for precision treatments in managing terminal conditions. Endeavor BioMedicines strives to improve patient outcomes and enhance quality of life for those affected by this challenging illness.

Eikon Therapeutics, Inc. is a biopharmaceutical company based in Hayward, California, focused on developing innovative treatments for chronic and life-threatening diseases. Founded in 2019, the company employs advanced super-resolution microscopy and live-cell imaging techniques to discover drugs targeting previously intractable proteins. By integrating biology, engineering, and chemistry, Eikon Therapeutics aims to enhance the understanding of cellular processes and improve drug discovery efficiency. Its proprietary platforms allow for the sensitive identification of compound-protein interactions, enabling the direct measurement of how chemical compounds affect individual proteins in live cells. This novel approach seeks to unlock new therapeutic opportunities and expand the company's pipeline of potential medications.

Freenome, Inc. is a biotechnology company based in South San Francisco, California, founded in 2014. It specializes in developing artificial intelligence-driven genomic solutions for the early detection of cancer. The company focuses on creating simple, non-invasive blood tests that can identify early-stage cancer and assist in treatment selection, thus enabling proactive disease management. Freenome’s multi-omics platform employs proprietary algorithms to enhance disease screening processes, aiming to facilitate timely interventions and improve treatment effectiveness. In addition to its diagnostic products, Freenome also offers clinical research services to support its mission of transforming cancer management through systematic early detection.

Farmers Business Network, Inc. is an independent agricultural technology and commerce platform that connects farmers through a farmer-to-farmer network. It aims to enhance the economic viability of farms and promote sustainable practices. By leveraging data science, FBN provides agronomic insights, enabling farmers to make informed decisions regarding their crops and operations. The platform allows members to share information, purchase inputs directly from manufacturers, and navigate the market more effectively. Additionally, FBN assists farmers in selling their crops independently and offers various insurance options. With over 800 employees, Farmers Business Network supports members who collectively farm more than 80 million acres across the United States, Canada, and Australia, with headquarters in multiple locations including California, Illinois, South Dakota, Alberta, and Perth.

Nextdoor, Inc. operates a social networking platform designed to facilitate local conversations and connections among neighbors. Founded in 2007 and headquartered in San Francisco, the company aims to cultivate a kinder, more connected world by enabling residents to engage with each other, local businesses, services, and community news. The platform includes features such as Help Map, which allows users to offer assistance to vulnerable neighbors, particularly during the Covid-19 pandemic. Nextdoor serves neighborhoods globally, including in the United States, the United Kingdom, Germany, France, and several other countries. The company is privately held and has received investment from notable firms, reinforcing its mission to foster real-world connections and community support.

Aurora is a self-driving vehicle company providing a platform that brings software and data services to operate passenger vehicles. To move both people and goods, the company develops Aurora Driver, a platform that brings together software, hardware, and data services to operate passenger vehicles, light commercial vehicles, and heavy-duty trucks. Aurora is backed by Amazon and Sequoia, among others, and partners with industry leaders including Toyota, Uber, Volvo, and Paccar. Aurora tests its vehicles in the Bay Area, Pittsburgh, and Dallas. The company has offices in those areas as well as in Bozeman, MT; Seattle, WA; Louisville, CO; and Wixom, MI.

Nuro, Inc. is a technology company established in 2016 and headquartered in Mountain View, California. The company specializes in manufacturing self-driving vehicles specifically designed for local goods transportation. Nuro's autonomous delivery service enhances local commerce by enabling merchants to efficiently deliver a wide range of products, including food and pharmaceuticals, directly to customers. Their fleet of electric, fully autonomous vehicles aims to provide quick, affordable, and safe delivery options, thereby transforming the logistics of local deliveries.

Honor is the largest senior care network and technology platform globally, dedicated to enhancing the quality of life for older adults and their families. Founded in 2014 in San Francisco by Cameron Ring, Monica Lo, Sandy Jen, and Seth Sternberg, the company aims to improve in-home care services for seniors. In 2021, Honor expanded its reach by acquiring Home Instead, which strengthened its network and introduced a relationship-based care model. The company combines workforce management and technology expertise with personalized care delivered through a network of third-party providers. This integrated approach allows older adults to receive reliable, transparent, and quality care, enabling them to live safely and comfortably in their own homes.

Coalition, Inc. specializes in providing insurance coverage and risk management tools aimed at mitigating cyber risk for a diverse range of industries, including healthcare, retail, technology, real estate, non-profits, and more. Founded in 2017 and headquartered in San Francisco, Coalition combines comprehensive insurance solutions with proactive cybersecurity tools. The company's Active Risk Platform offers features such as automated security alerts, threat intelligence, and expert guidance to enhance organizational resilience against cyber threats. Backed by prominent global insurers, Coalition operates in the United States and Canada, delivering its security products to businesses worldwide. By integrating risk assessment, security protection, and response strategies, Coalition helps organizations effectively manage and reduce their exposure to cyber-attacks.

Checkr, Inc. is a technology company specializing in the background check industry. Founded in 2014 and headquartered in San Francisco, California, Checkr offers a range of screening services, including criminal record checks, driving checks, and identity verification. The company utilizes advanced technology, including artificial intelligence and machine learning, to deliver faster and more efficient background checks compared to traditional providers. Its platform not only enhances hiring transparency and fairness but also assists businesses in complying with regulations and improving operational efficiency. Checkr serves various sectors, including financial services, healthcare, retail, and technology, providing solutions that cater to the evolving needs of the workforce.

ServiceTitan, Inc. offers a cloud-based business management software tailored for the home service industry, including sectors such as HVAC, plumbing, electricity, and various other service businesses. Founded in 2007 and based in Glendale, California, with additional offices in Atlanta and Armenia, ServiceTitan's platform enhances operations by providing tools for scheduling, dispatching, invoicing, and customer relationship management. The software integrates various functionalities, such as marketing automation, reporting, and financing, to streamline processes and improve customer service. By equipping businesses with a comprehensive software solution, ServiceTitan aims to drive growth and efficiency in an industry that has traditionally lagged in technology adoption.

PROCEPT BioRobotics Corporation is a surgical robotics company based in Redwood Shores, California, that specializes in developing innovative solutions for urology. The company is known for its AquaBeam Robotic System, an advanced, image-guided surgical robot designed for minimally invasive procedures, particularly for treating benign prostatic hyperplasia (BPH). BPH affects approximately 40 million men in the United States and can lead to lower urinary tract symptoms (LUTS). PROCEPT's Aquablation therapy aims to provide effective and durable treatment outcomes that are not influenced by prostate size or the surgeon's experience. The company has established a robust body of clinical evidence, including nine clinical studies and over 100 peer-reviewed publications, demonstrating the clinical advantages of its Aquablation therapy. Revenue is primarily generated through the sales of the AquaBeam Robotic System and its disposable handpieces.

Element Biosciences, Inc. is a life science company based in San Diego, California, that specializes in developing innovative genetic analysis tools for research and diagnostics. Established in 2017, the company focuses on creating a modular and high-performing DNA sequencing platform designed to provide high-quality data and workflow flexibility. Their proprietary technology enhances the signal-to-noise ratio and incorporates advancements in surface chemistry, instrumentation, and biochemistry. This approach significantly reduces both operational and capital costs while ensuring superior sequencing data quality, thereby making next-generation sequencing technology more accessible to medical researchers and improving their research capabilities.

GOAT is a global marketplace specializing in authentic sneakers, apparel, and accessories from contemporary luxury brands. Founded in 2015 and headquartered in Los Angeles, the platform connects buyers and sellers, allowing users to make offers on desired styles and access exclusive drops. GOAT features a wide selection of over 350 brands, leveraging innovative technology to ensure product authenticity and enhance the sneaker commerce experience. With thirteen physical locations across the United States, Asia, and Europe, the company operates distribution and authentication centers that serve 170 international markets. GOAT caters to a community of over 20 million members in 164 countries, positioning itself uniquely between the primary and resale markets to deliver authentic products from past, present, and future styles.

Clear Labs, Inc. is a food analytics company based in Menlo Park, California, founded in 2013. The company specializes in providing a comprehensive analytics platform that analyzes the molecular contents of food and ingredients. Its offerings include Clear Dx™ and Clear Safety™, which utilize next-generation sequencing and data analytics for food safety testing and infectious disease surveillance. Clear Labs serves food manufacturers, suppliers, and retailers by ensuring transparency throughout the supply chain and testing products for various factors such as authenticity, contamination, allergens, and nutritional content. The platform delivers actionable insights that enhance safety and operational efficiency while supporting public health initiatives. Through its integrated genomics system, Clear Labs aims to simplify complex diagnostics across clinical and applied markets, making genomic insights accessible to labs, hospitals, and businesses.

ABL Space Systems specializes in designing and manufacturing rockets for the launch of small satellites. Incorporated in 2017 and based in El Segundo, California, the company focuses on developing low-cost and reliable launch vehicles, with its primary product being the RS1 rocket. This vehicle is capable of carrying payloads of up to 1,350 kilograms to Low Earth Orbit (LEO) and supports various configurations, including multi-manifest and dedicated deployments. In addition to the RS1, ABL also creates the GS0 ground system, which facilitates rapid deployment and integration of launch operations at multiple sites. The company operates from a 30,000 square foot facility dedicated to research, development, and production, and is privately owned, supported by a group of private equity investors.

Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.

Databricks Inc. offers a unified data analytics cloud platform that simplifies data engineering and supports collaborative data science. Its core product, Databricks, enables organizations to process and analyze large datasets efficiently, leveraging tools like Apache Spark. The platform is designed for real-time experimentation and robust deployment of production applications, catering to developers and data scientists. Additionally, Databricks provides Databricks Delta, a data management system that combines the scalability of a data warehouse with low-latency streaming capabilities. The company also offers MLflow for managing the machine learning lifecycle and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including healthcare, finance, manufacturing, and telecommunications. Founded in 2013 and headquartered in San Francisco, with additional offices in London, Amsterdam, and Bengaluru, Databricks has established strategic partnerships to enhance its offerings and foster innovation in data and AI technologies.

Design Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for degenerative disorders linked to nucleotide repeat expansions. Founded in 2017 and headquartered in Solana Beach, California, the company is advancing its lead program aimed at treating Friedreich’s ataxia. Additionally, Design Therapeutics is exploring treatments for other conditions such as Fragile X syndrome and myotonic dystrophy, utilizing its proprietary GeneTACTM technology, which involves small-molecule gene-targeted therapeutics designed to modify the underlying causes of these inherited diseases. The company is committed to addressing serious monogenic disorders driven by nucleotide repeat mutations through its ongoing research and development efforts.

Sila is a battery materials company founded in 2011 and headquartered in California, United States. It specializes in manufacturing energy-dense lithium-ion batteries designed for electric vehicles and consumer electronics. Sila collaborates with automotive original equipment manufacturers (OEMs) to accelerate product development and partners with battery manufacturers to enhance commercial cell production. The company focuses on providing advanced battery materials that improve energy storage capabilities, enabling the production of small, light, and long-lasting devices. By offering superior performance and quality control, Sila aims to facilitate the mass adoption of affordable, long-range electric vehicles while maintaining safety and cycle life standards.

Genesis Therapeutics Inc. is a biotechnology company based in South San Francisco, California, that focuses on developing small molecule drug candidates aimed at treating patients with severe and debilitating disorders. Established in 2019, the company harnesses a proprietary artificial intelligence platform that employs advanced deep neural networks and biophysical simulation techniques to enhance drug discovery and molecular design. By combining these innovative technologies with a scalable computing infrastructure, Genesis Therapeutics aims to improve the efficiency and accuracy of molecular research. This approach not only facilitates the generation and analysis of novel drug candidates but also holds the potential to significantly advance clinical outcomes in the medical community.

Imago BioSciences is a clinical-stage biotechnology company based in Redwood City, California, that specializes in developing innovative medicines for hematologic diseases. Founded in 2012, the company focuses on therapeutics that target genetic and epigenetic factors, specifically through the inhibition of lysine-specific demethylase 1 (LSD1), an enzyme crucial in blood cell production. Imago BioSciences aims to address significant medical challenges associated with conditions such as leukemia, myelodysplastic syndrome, and other bone marrow disorders. Its lead product candidate, Bomedemstat, is an orally available small molecule designed to treat certain myeloproliferative neoplasms, with the goal of altering disease progression and improving the quality and longevity of patients' lives.

Nuro, Inc. is a technology company established in 2016 and headquartered in Mountain View, California. The company specializes in manufacturing self-driving vehicles specifically designed for local goods transportation. Nuro's autonomous delivery service enhances local commerce by enabling merchants to efficiently deliver a wide range of products, including food and pharmaceuticals, directly to customers. Their fleet of electric, fully autonomous vehicles aims to provide quick, affordable, and safe delivery options, thereby transforming the logistics of local deliveries.

Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing innovative medicines for neurological diseases. The company's proprietary pipeline includes several product candidates, notably LP352, a next-generation 5-HT2C agonist intended for treating developmental and epileptic encephalopathies. Additionally, Longboard is evaluating LP143, a full agonist of the cannabinoid type 2 receptor, which targets conditions such as amyotrophic lateral sclerosis and Parkinson's disease, as well as LP659, a selective modulator for multiple central nervous system neuroinflammatory disorders. Longboard Pharmaceuticals aims to optimize pharmacology and pharmacokinetics across its drug candidates, enhancing therapeutic outcomes for patients with rare neurological conditions. The company was incorporated in 2020 and was previously known as Arena Neuroscience, Inc.

Honor is the largest senior care network and technology platform globally, dedicated to enhancing the quality of life for older adults and their families. Founded in 2014 in San Francisco by Cameron Ring, Monica Lo, Sandy Jen, and Seth Sternberg, the company aims to improve in-home care services for seniors. In 2021, Honor expanded its reach by acquiring Home Instead, which strengthened its network and introduced a relationship-based care model. The company combines workforce management and technology expertise with personalized care delivered through a network of third-party providers. This integrated approach allows older adults to receive reliable, transparent, and quality care, enabling them to live safely and comfortably in their own homes.

Allbirds, Inc. is a San Francisco-based company founded in 2015 that specializes in manufacturing eco-friendly footwear and apparel. The company offers a variety of products, including wool runners, tree runners, and loungers for men, women, and children, as well as insoles. Allbirds focuses on using premium natural materials to create sustainable footwear designed for everyday life. The brand is committed to blending comfort, good design, and sustainability, aiming to shift the shoe industry towards a more thoughtful approach. Its products are sold through both physical retail locations and online platforms, with the majority of sales generated in the United States.

Freenome, Inc. is a biotechnology company based in South San Francisco, California, founded in 2014. It specializes in developing artificial intelligence-driven genomic solutions for the early detection of cancer. The company focuses on creating simple, non-invasive blood tests that can identify early-stage cancer and assist in treatment selection, thus enabling proactive disease management. Freenome’s multi-omics platform employs proprietary algorithms to enhance disease screening processes, aiming to facilitate timely interventions and improve treatment effectiveness. In addition to its diagnostic products, Freenome also offers clinical research services to support its mission of transforming cancer management through systematic early detection.

Kronos Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to discovering and developing innovative cancer therapeutics. Founded in 2017 and headquartered in San Mateo, California, the company focuses on targeting dysregulated transcription factors and oncogenic signaling pathways. Its lead candidate, entospletinib, is a selective inhibitor of spleen tyrosine kinase aimed at treating acute myeloid leukemia. Additionally, Kronos Bio is developing KB-0742, an orally bioavailable inhibitor of cyclin-dependent kinase 9, intended for MYC-amplified solid tumors. By leveraging advanced technologies such as high-throughput small-molecule microarrays and targeted protein degradation, Kronos Bio aims to identify effective compounds that can modulate historically undruggable cancer targets, ultimately striving to improve patient outcomes through precision medicine.

Farmers Business Network, Inc. is an independent agricultural technology and commerce platform that connects farmers through a farmer-to-farmer network. It aims to enhance the economic viability of farms and promote sustainable practices. By leveraging data science, FBN provides agronomic insights, enabling farmers to make informed decisions regarding their crops and operations. The platform allows members to share information, purchase inputs directly from manufacturers, and navigate the market more effectively. Additionally, FBN assists farmers in selling their crops independently and offers various insurance options. With over 800 employees, Farmers Business Network supports members who collectively farm more than 80 million acres across the United States, Canada, and Australia, with headquarters in multiple locations including California, Illinois, South Dakota, Alberta, and Perth.

VelosBio, Inc. is a clinical-stage biopharmaceutical company based in San Diego, California, focused on developing innovative antibody-drug conjugates (ADCs) to treat various forms of cancer, including hematological cancers and solid tumors. The company's primary area of research centers on targeting receptor tyrosine kinase-like orphan receptor 1 (ROR1), a cell-surface protein found in numerous tumors but absent in normal tissues, which makes it a promising target for cancer therapy. VelosBio's lead product, VLS-101, is a ROR1-directed ADC that has shown positive preclinical results and aims to provide new treatment options for patients. Founded in 2017, VelosBio operates under the umbrella of Merck & Co., Inc. as of December 2020, focusing on developing targeted therapies that can be administered alone or in combination with other treatments across a wide range of cancer types.

DoorDash, Inc. is a logistics platform founded in 2013 and headquartered in San Francisco, California. It connects merchants, consumers, and delivery personnel, primarily in the United States, but has expanded its services to Europe through the acquisition of Wolt in 2022. The company operates a marketplace that allows merchants, including restaurants, grocery stores, and retailers, to reach customers by offering food and other goods for pickup or delivery. DoorDash provides a range of services to help merchants address critical challenges, including customer acquisition, payment processing, and customer support, while also offering a white-label logistics service called DoorDash Drive. The company aims to enhance local economies by facilitating connections between consumers and their favorite businesses.

Insitro, Inc. is a data-driven company focused on drug discovery and development, particularly targeting nonalcoholic steatohepatitis (NASH). Founded in 2018 by Daphne Koller and based in South San Francisco, California, Insitro harnesses machine learning and high-throughput biology to revolutionize the process of drug discovery. The company creates extensive functional genomic data sets and integrates them with patient data through innovative machine learning techniques. This approach allows Insitro to build predictive models that enhance target selection, streamline the design of therapeutics, and optimize drug development strategies. By addressing critical challenges in pharmaceutical research and development, Insitro aims to accelerate the delivery of new and effective treatments to patients.

RefleXion Medical Inc. is a medical equipment company specializing in the development of biologically-guided radiotherapy systems for cancer treatment. Its flagship innovation, the RefleXion X1 machine, is designed to deliver advanced radiation therapies such as stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS). The company's biologically-guided radiotherapy (BgRT) technology utilizes positron-emission tomography (PET) imaging data to allow tumors to continuously signal their location during treatment, enabling the possibility of treating multiple tumors in a single session, especially in cases of metastasized cancers. This real-time adaptation to the biological characteristics of tumors represents a significant advancement in radiation oncology. RefleXion Medical, incorporated in 2009 and based in Hayward, California, has established strategic partnerships with Telix Pharmaceuticals Limited and HealthMyne Inc. to further its mission in cancer treatment innovation.

Airbnb, Inc. operates a global online platform that connects hosts with guests seeking short-term accommodations and unique experiences. Founded in 2007 and headquartered in San Francisco, the company facilitates bookings for a diverse range of lodging options, including private rooms, luxury villas, and boutique hotels. As one of the largest alternative accommodation travel agencies in the world, Airbnb's marketplace model allows over 5 million hosts to list their properties, resulting in more than 8 million active accommodation listings across nearly every country. The company generates revenue primarily through transaction fees on online bookings, with a significant portion of its earnings coming from the North American region.

HashiCorp, Inc. is an open-source software company based in San Francisco, California, founded in 2012 by Mitchell Hashimoto and Armon Dadgar. The company specializes in developing multi-cloud infrastructure automation software that addresses the challenges of cloud adoption. HashiCorp's primary products include Terraform, a cloud infrastructure as code tool for provisioning and managing resources; Vault, which secures and controls access to sensitive data; Nomad, a work orchestrator for deploying and managing applications across various environments; and Consul, a tool for service discovery and orchestration. Additionally, HashiCorp offers Vagrant for creating reproducible development environments and Packer for generating identical machine images for multiple platforms. The company aims to provide consistent workflows and a standardized approach to automate infrastructure processes, thereby enabling organizations to effectively run distributed applications in both public and private cloud environments.

Outset Medical, Inc. is a medical technology company based in San Jose, California, focused on innovating hemodialysis systems. The company has developed Tablo, a compact dialysis machine designed for use in both acute and chronic care settings. This system integrates essential features such as water purification, on-demand dialysate production, and advanced software capabilities, including wireless data connectivity and sensor-based automation. By simplifying the dialysis process, Tablo aims to reduce costs and enhance the experience for both patients and healthcare providers. Founded in 2003 and originally named Home Dialysis Plus, Ltd., Outset Medical rebranded in 2015 to reflect its commitment to transforming dialysis care.

Databricks Inc. offers a unified data analytics cloud platform that simplifies data engineering and supports collaborative data science. Its core product, Databricks, enables organizations to process and analyze large datasets efficiently, leveraging tools like Apache Spark. The platform is designed for real-time experimentation and robust deployment of production applications, catering to developers and data scientists. Additionally, Databricks provides Databricks Delta, a data management system that combines the scalability of a data warehouse with low-latency streaming capabilities. The company also offers MLflow for managing the machine learning lifecycle and Delta Lake for handling batch and streaming data. Databricks serves a diverse range of industries, including healthcare, finance, manufacturing, and telecommunications. Founded in 2013 and headquartered in San Francisco, with additional offices in London, Amsterdam, and Bengaluru, Databricks has established strategic partnerships to enhance its offerings and foster innovation in data and AI technologies.

Checkr, Inc. is a technology company specializing in the background check industry. Founded in 2014 and headquartered in San Francisco, California, Checkr offers a range of screening services, including criminal record checks, driving checks, and identity verification. The company utilizes advanced technology, including artificial intelligence and machine learning, to deliver faster and more efficient background checks compared to traditional providers. Its platform not only enhances hiring transparency and fairness but also assists businesses in complying with regulations and improving operational efficiency. Checkr serves various sectors, including financial services, healthcare, retail, and technology, providing solutions that cater to the evolving needs of the workforce.

Freenome, Inc. is a biotechnology company based in South San Francisco, California, founded in 2014. It specializes in developing artificial intelligence-driven genomic solutions for the early detection of cancer. The company focuses on creating simple, non-invasive blood tests that can identify early-stage cancer and assist in treatment selection, thus enabling proactive disease management. Freenome’s multi-omics platform employs proprietary algorithms to enhance disease screening processes, aiming to facilitate timely interventions and improve treatment effectiveness. In addition to its diagnostic products, Freenome also offers clinical research services to support its mission of transforming cancer management through systematic early detection.

Aurora is a self-driving vehicle company providing a platform that brings software and data services to operate passenger vehicles. To move both people and goods, the company develops Aurora Driver, a platform that brings together software, hardware, and data services to operate passenger vehicles, light commercial vehicles, and heavy-duty trucks. Aurora is backed by Amazon and Sequoia, among others, and partners with industry leaders including Toyota, Uber, Volvo, and Paccar. Aurora tests its vehicles in the Bay Area, Pittsburgh, and Dallas. The company has offices in those areas as well as in Bozeman, MT; Seattle, WA; Louisville, CO; and Wixom, MI.

Minted LLC is a design marketplace based in San Francisco, California, that connects consumers with independent artists from around the world. Established in 2007, the company specializes in a wide range of creative products, including art, home decor, and stationery cards. Minted utilizes crowdsourcing technology to empower consumers to vote on designs they wish to see sold, ensuring a continuously fresh and trend-oriented product lineup. The platform offers various items such as wedding, baby, and seasonal cards, limited edition prints, custom stamps, and textiles like pillows and table linens. By manufacturing winning designs and providing artists with a platform to showcase their work, Minted not only promotes independent design but also collaborates with major retailers and brands through licensing and wholesale partnerships.

ShockWave Medical, Inc. is a medical device company based in Santa Clara, California, focused on developing and commercializing intravascular lithotripsy technology to treat calcified plaque associated with peripheral vascular, coronary vascular, and heart valve diseases. The company offers a range of catheters, including M5 for above-the-knee peripheral artery disease, C2 for coronary artery disease, and S4 for below-the-knee peripheral artery disease. Its Lithoplasty™ technology utilizes sonic pressure waves to facilitate the treatment of rigid vascular and valvular lesions, allowing for improved angioplasty outcomes and reduced reliance on stents. This innovative approach enhances vessel preparation before procedures such as drug eluting balloon placement and trans-catheter aortic valve replacement. ShockWave Medical serves a diverse clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, through a network of sales representatives, managers, and distributors across the United States and Europe. Incorporated in 2009, the company is committed to transforming cardiovascular care and improving patient outcomes.

ServiceTitan, Inc. offers a cloud-based business management software tailored for the home service industry, including sectors such as HVAC, plumbing, electricity, and various other service businesses. Founded in 2007 and based in Glendale, California, with additional offices in Atlanta and Armenia, ServiceTitan's platform enhances operations by providing tools for scheduling, dispatching, invoicing, and customer relationship management. The software integrates various functionalities, such as marketing automation, reporting, and financing, to streamline processes and improve customer service. By equipping businesses with a comprehensive software solution, ServiceTitan aims to drive growth and efficiency in an industry that has traditionally lagged in technology adoption.

Allbirds, Inc. is a San Francisco-based company founded in 2015 that specializes in manufacturing eco-friendly footwear and apparel. The company offers a variety of products, including wool runners, tree runners, and loungers for men, women, and children, as well as insoles. Allbirds focuses on using premium natural materials to create sustainable footwear designed for everyday life. The brand is committed to blending comfort, good design, and sustainability, aiming to shift the shoe industry towards a more thoughtful approach. Its products are sold through both physical retail locations and online platforms, with the majority of sales generated in the United States.

PagerDuty, Inc. operates a digital operations management platform designed to enhance real-time operational capabilities for businesses globally. Founded in 2009 and headquartered in San Francisco, the company provides a software-as-a-service solution that integrates digital signals from various systems and devices with human response data, enabling teams to respond effectively to incidents and disruptions. Its platform offers a range of services, including event intelligence, incident response, on-call management, and advanced analytics, catering to industries such as technology, telecommunications, retail, and financial services. With over 10,000 customers, including notable names like Comcast and Slack, PagerDuty empowers organizations to proactively manage incidents and ensure exceptional customer experiences. The company's partnership with Tata Consultancy Services further supports efforts in digital transformation.

Outset Medical, Inc. is a medical technology company based in San Jose, California, focused on innovating hemodialysis systems. The company has developed Tablo, a compact dialysis machine designed for use in both acute and chronic care settings. This system integrates essential features such as water purification, on-demand dialysate production, and advanced software capabilities, including wireless data connectivity and sensor-based automation. By simplifying the dialysis process, Tablo aims to reduce costs and enhance the experience for both patients and healthcare providers. Founded in 2003 and originally named Home Dialysis Plus, Ltd., Outset Medical rebranded in 2015 to reflect its commitment to transforming dialysis care.

Slack Technologies, Inc. operates a cloud-based communication and collaboration platform designed to enhance organizational communication. Founded in 2009 and headquartered in San Francisco, California, Slack enables users to exchange messages, share files, and integrate with a variety of business tools and services. The platform is utilized by teams across multiple industries, from startups to large enterprises, promoting increased efficiency and productivity. Slack's offerings are provided under a software-as-a-service model, and the company also manages the Slack Fund, which invests in teams developing innovative products aimed at improving workplace productivity.

D2iq, Inc. is a technology company that specializes in developing a datacenter operating system (DCOS) to streamline the management and deployment of applications across physical and cloud-based infrastructures. Founded in 2013 and headquartered in San Francisco, D2iq's core product, Mesosphere DCOS, is built on open-source technology and simplifies the execution of applications in a data center environment, akin to launching apps on a personal computer. The company also offers solutions such as Mesosphere Infinity, which facilitates the transformation of Big Data into actionable insights, and Conductor, an interactive platform for hands-on cloud-native training. In addition to its software offerings, D2iq provides architectural and consulting services, including expert consultations, on-site training, and custom installations. The company's strategic alliances with prominent firms enhance its service offerings, enabling organizations to adopt open-source and cloud-native innovations effectively.

Checkr, Inc. is a technology company specializing in the background check industry. Founded in 2014 and headquartered in San Francisco, California, Checkr offers a range of screening services, including criminal record checks, driving checks, and identity verification. The company utilizes advanced technology, including artificial intelligence and machine learning, to deliver faster and more efficient background checks compared to traditional providers. Its platform not only enhances hiring transparency and fairness but also assists businesses in complying with regulations and improving operational efficiency. Checkr serves various sectors, including financial services, healthcare, retail, and technology, providing solutions that cater to the evolving needs of the workforce.

RefleXion Medical Inc. is a medical equipment company specializing in the development of biologically-guided radiotherapy systems for cancer treatment. Its flagship innovation, the RefleXion X1 machine, is designed to deliver advanced radiation therapies such as stereotactic body radiotherapy (SBRT) and stereotactic radiosurgery (SRS). The company's biologically-guided radiotherapy (BgRT) technology utilizes positron-emission tomography (PET) imaging data to allow tumors to continuously signal their location during treatment, enabling the possibility of treating multiple tumors in a single session, especially in cases of metastasized cancers. This real-time adaptation to the biological characteristics of tumors represents a significant advancement in radiation oncology. RefleXion Medical, incorporated in 2009 and based in Hayward, California, has established strategic partnerships with Telix Pharmaceuticals Limited and HealthMyne Inc. to further its mission in cancer treatment innovation.

Farmers Business Network, Inc. is an independent agricultural technology and commerce platform that connects farmers through a farmer-to-farmer network. It aims to enhance the economic viability of farms and promote sustainable practices. By leveraging data science, FBN provides agronomic insights, enabling farmers to make informed decisions regarding their crops and operations. The platform allows members to share information, purchase inputs directly from manufacturers, and navigate the market more effectively. Additionally, FBN assists farmers in selling their crops independently and offers various insurance options. With over 800 employees, Farmers Business Network supports members who collectively farm more than 80 million acres across the United States, Canada, and Australia, with headquarters in multiple locations including California, Illinois, South Dakota, Alberta, and Perth.

ShockWave Medical, Inc. is a medical device company based in Santa Clara, California, focused on developing and commercializing intravascular lithotripsy technology to treat calcified plaque associated with peripheral vascular, coronary vascular, and heart valve diseases. The company offers a range of catheters, including M5 for above-the-knee peripheral artery disease, C2 for coronary artery disease, and S4 for below-the-knee peripheral artery disease. Its Lithoplasty™ technology utilizes sonic pressure waves to facilitate the treatment of rigid vascular and valvular lesions, allowing for improved angioplasty outcomes and reduced reliance on stents. This innovative approach enhances vessel preparation before procedures such as drug eluting balloon placement and trans-catheter aortic valve replacement. ShockWave Medical serves a diverse clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, through a network of sales representatives, managers, and distributors across the United States and Europe. Incorporated in 2009, the company is committed to transforming cardiovascular care and improving patient outcomes.

Eventbrite, Inc. is a ticketing and experience technology platform that operates both in the United States and internationally. Founded in 2006 and headquartered in San Francisco, California, the company enables users to find, create, and manage a variety of events, including conferences, workshops, music performances, and fundraisers. Its platform integrates essential tools for planning, promoting, and producing live events, which helps event creators streamline processes, minimize costs, and enhance ticket sales. Eventbrite also offers mobile applications to facilitate event management and ticket sales. The company primarily generates revenue from its operations in the United States, serving a diverse range of customers worldwide.

Guardant Health, Inc. is a precision oncology company based in Redwood City, California, specializing in blood tests, data analytics, and related services for cancer detection and treatment. The company is known for its innovative liquid biopsy tests designed for advanced-stage cancer, including Guardant360, which assesses multiple cancer-related genes, and GuardantOMNI, which offers a broader gene panel for immuno-oncology applications. Additionally, Guardant Health provides LUNAR-1, aimed at detecting minimal residual disease in cancer survivors, and is developing LUNAR-2 for early cancer detection in high-risk individuals. The company also supports biopharmaceutical firms and medical institutions with services such as companion diagnostic development, regulatory approval, and clinical trial referrals. Guardant Health has established collaborations, including one with Radius Health for developing a companion diagnostic related to elacestrant. Since its incorporation in 2011, the company has focused on advancing patient health through technological innovations in oncology.

Outset Medical, Inc. is a medical technology company based in San Jose, California, focused on innovating hemodialysis systems. The company has developed Tablo, a compact dialysis machine designed for use in both acute and chronic care settings. This system integrates essential features such as water purification, on-demand dialysate production, and advanced software capabilities, including wireless data connectivity and sensor-based automation. By simplifying the dialysis process, Tablo aims to reduce costs and enhance the experience for both patients and healthcare providers. Founded in 2003 and originally named Home Dialysis Plus, Ltd., Outset Medical rebranded in 2015 to reflect its commitment to transforming dialysis care.

ShockWave Medical, Inc. is a medical device company based in Santa Clara, California, focused on developing and commercializing intravascular lithotripsy technology to treat calcified plaque associated with peripheral vascular, coronary vascular, and heart valve diseases. The company offers a range of catheters, including M5 for above-the-knee peripheral artery disease, C2 for coronary artery disease, and S4 for below-the-knee peripheral artery disease. Its Lithoplasty™ technology utilizes sonic pressure waves to facilitate the treatment of rigid vascular and valvular lesions, allowing for improved angioplasty outcomes and reduced reliance on stents. This innovative approach enhances vessel preparation before procedures such as drug eluting balloon placement and trans-catheter aortic valve replacement. ShockWave Medical serves a diverse clientele, including interventional cardiologists, vascular surgeons, and interventional radiologists, through a network of sales representatives, managers, and distributors across the United States and Europe. Incorporated in 2009, the company is committed to transforming cardiovascular care and improving patient outcomes.

Glassdoor, Inc. operates an online job and career community that connects job seekers with potential employers. Founded in 2007 and headquartered in Mill Valley, California, the platform provides a wealth of user-generated content, including company reviews, salary reports, interview questions, and office photos. This information assists individuals in making informed career decisions. Glassdoor allows employers to post job openings across various sectors such as administrative, engineering, finance, healthcare, IT, and sales, among others. The service is accessible through its website and mobile applications on iOS and Android. With additional offices in cities like San Francisco, Chicago, Toronto, and Paris, Glassdoor serves a global audience and operates as a subsidiary of Recruit Holdings Co., Ltd.

Snap Inc. is a global camera company based in Santa Monica, California, founded in 2010. It is best known for its flagship product, Snapchat, a multimedia messaging application that allows users to send photos and videos that disappear after being viewed. The app has gained popularity, particularly among younger users, for its unique features, including filters, lenses, and Stories, as well as augmented reality experiences and gaming. In addition to Snapchat, Snap Inc. offers several other tools such as Snap Map for location sharing, Memories for saving and organizing Snaps, and the Discover platform for accessing content from publishers and creators. The company also produces Spectacles, sunglasses equipped with a built-in camera that enables users to capture content from a first-person perspective. Through its innovative approach to communication and technology, Snap Inc. continues to evolve and expand its offerings in the realms of social media and digital content creation.

Audentes Therapeutics, a clinical-stage biotechnology company based in San Francisco, is dedicated to developing and commercializing gene therapy products for patients with serious, life-threatening rare diseases resulting from single gene defects. The company is advancing several therapies, including AT132 and AT342, which are in Phase I/II clinical studies for treating X-linked myotubular myopathy and Crigler-Najjar syndrome, respectively. Additionally, it is exploring treatments for Pompe disease and catecholaminergic polymorphic ventricular tachycardia, along with vectorized antisense treatments for Duchenne muscular dystrophy and myotonic dystrophy type 1. Audentes has established collaborative agreements for research and development with Genethon and the University of Pennsylvania. Founded in 2012, Audentes Therapeutics became a subsidiary of Astellas US Holding in 2020 and operates as Astellas Gene Therapies, focusing on leveraging its expertise in gene therapy research and commercialization.

Airbnb, Inc. operates a global online platform that connects hosts with guests seeking short-term accommodations and unique experiences. Founded in 2007 and headquartered in San Francisco, the company facilitates bookings for a diverse range of lodging options, including private rooms, luxury villas, and boutique hotels. As one of the largest alternative accommodation travel agencies in the world, Airbnb's marketplace model allows over 5 million hosts to list their properties, resulting in more than 8 million active accommodation listings across nearly every country. The company generates revenue primarily through transaction fees on online bookings, with a significant portion of its earnings coming from the North American region.

aTyr Pharma is a biotherapeutics company based in San Diego, California, specializing in the discovery and development of innovative medicines utilizing novel immunological pathways. The company focuses primarily on ATYR1923, a clinical-stage fusion protein designed to down-regulate immune engagement in interstitial lung diseases by binding to the neuropilin-2 receptor. This candidate is currently undergoing Phase 1b/2a clinical trials. aTyr Pharma has established a strong intellectual property portfolio centered around Physiocrine-based compositions and therapeutic applications, particularly in immunomodulation disorders related to inflammation and immunity. Additionally, the company has formed collaborations with several institutions, including the University of Nebraska Medical Center, CSL Behring, Boston Children’s Hospital, and the Medical University of South Carolina, to advance its research and development efforts. Founded in 2005 by a prominent scientist from The Scripps Research Institute, aTyr is supported by leading life sciences investors.

Lookout, Inc. is a cybersecurity company specializing in cloud-based technology solutions for mobile security. It offers personal security applications for both Android and iOS devices, focusing on mobile threat protection and theft prevention. Lookout's product suite also includes the Mobile Intelligence Center, which facilitates real-time access to mobile threat data, and an App Vetting API that secures enterprise and commercial app stores. The company aims to empower organizations to implement Bring Your Own Device (BYOD) policies, ensure compliance, and combat advanced mobile threats. Founded in 2005 and headquartered in San Francisco, California, Lookout has expanded its presence with offices in several global locations, including Boston, London, and Tokyo. It serves a diverse clientele, including enterprises, government agencies, and millions of consumers, by providing solutions that safeguard sensitive data across devices, applications, networks, and clouds.

New Relic is a digital intelligence company headquartered in San Francisco, California, founded in 2008. It provides a cloud-based unified data platform designed to help businesses, brands, and software engineers monitor, debug, and enhance their entire technology stack. With over 14,000 paid business accounts, New Relic's platform offers actionable insights through a suite of products that includes diagnostics, reporting, alerting, transaction monitoring, and performance monitoring capabilities. By delivering full-stack visibility and analytics, New Relic aims to drive digital business results and improve operational efficiency for its clients.

Lending Club is an online financial community that brings together creditworthy borrowers and savvy investors so that both can benefit financially. They replace the high cost and complexity of bank lending with a faster, smarter way to borrow and invest. Founded in 2007, the company is headquartered in San Francisco, California, United States.

Cloudera, Inc. is a provider of data analytics and management solutions, operating primarily in the United States, Europe, and Asia. The company offers a comprehensive suite of products through its Subscription and Services segments. Its flagship Cloudera Enterprise Data Hub enables organizations to perform various analytics on a governed and secure data set across public and private clouds or data centers. Cloudera also provides a hybrid cloud solution known as Cloudera Data Warehouse for self-service analytics, along with tools like Cloudera Data Science and Engineering for big data processing and Cloudera Operational DB for real-time analytics. Additional offerings include the Hortonworks Data Platform, Cloudera DataFlow for data collection and analysis, and Cloudera SDX for security and governance. Cloudera supports its clients—corporate enterprises and public sector organizations—through software subscriptions and professional services that include consultation, training, and machine learning expertise. Founded in 2008 and headquartered in Palo Alto, California, Cloudera aims to transform complex data into actionable insights while ensuring efficiency and security.

Eventbrite, Inc. is a ticketing and experience technology platform that operates both in the United States and internationally. Founded in 2006 and headquartered in San Francisco, California, the company enables users to find, create, and manage a variety of events, including conferences, workshops, music performances, and fundraisers. Its platform integrates essential tools for planning, promoting, and producing live events, which helps event creators streamline processes, minimize costs, and enhance ticket sales. Eventbrite also offers mobile applications to facilitate event management and ticket sales. The company primarily generates revenue from its operations in the United States, serving a diverse range of customers worldwide.

Yub is an innovative offline affiliate network based in Mountain View, California, specializing in helping retailers and restaurants track consumer behavior from online interactions to actual purchases. By leveraging the online affiliate model, Yub facilitates a seamless connection between online engagement and in-store transactions, allowing businesses to effectively drive foot traffic and sales without requiring any integration or upgrades. The company offers user-friendly promotional options for consumers, positioning itself to transform how brick-and-mortar establishments attract and retain customers.

Eventbrite, Inc. is a ticketing and experience technology platform that operates both in the United States and internationally. Founded in 2006 and headquartered in San Francisco, California, the company enables users to find, create, and manage a variety of events, including conferences, workshops, music performances, and fundraisers. Its platform integrates essential tools for planning, promoting, and producing live events, which helps event creators streamline processes, minimize costs, and enhance ticket sales. Eventbrite also offers mobile applications to facilitate event management and ticket sales. The company primarily generates revenue from its operations in the United States, serving a diverse range of customers worldwide.

New Relic is a digital intelligence company headquartered in San Francisco, California, founded in 2008. It provides a cloud-based unified data platform designed to help businesses, brands, and software engineers monitor, debug, and enhance their entire technology stack. With over 14,000 paid business accounts, New Relic's platform offers actionable insights through a suite of products that includes diagnostics, reporting, alerting, transaction monitoring, and performance monitoring capabilities. By delivering full-stack visibility and analytics, New Relic aims to drive digital business results and improve operational efficiency for its clients.

Evernote builds apps and products that are defining the way individuals and teams work today. As one workspace that lives across people's phone, tablet and computer, Evernote is the place people write free from distraction, collect information, find what they need and present their ideas to the world. Whatever peole are working toward, Evernote’s job is to make sure they get there. Evernote is an independent, privately held company headquartered in Redwood City, California. Founded in 2007, Evernote products reach more than 100 million users worldwide. With nearly 400 employees and growing, they are always looking for talented individuals to join their global team.

Evernote builds apps and products that are defining the way individuals and teams work today. As one workspace that lives across people's phone, tablet and computer, Evernote is the place people write free from distraction, collect information, find what they need and present their ideas to the world. Whatever peole are working toward, Evernote’s job is to make sure they get there. Evernote is an independent, privately held company headquartered in Redwood City, California. Founded in 2007, Evernote products reach more than 100 million users worldwide. With nearly 400 employees and growing, they are always looking for talented individuals to join their global team.

Zynga Inc. is a prominent developer and operator of social games, offering a diverse portfolio that includes popular titles such as FarmVille, Words With Friends, and Zynga Poker. Founded in 2007 and headquartered in San Francisco, California, Zynga's games are accessible on mobile platforms like iOS and Android, as well as on social networking sites such as Facebook and Snapchat. The company generates revenue primarily through mobile game downloads, in-game sales of virtual goods, and advertising services, with the majority of its income stemming from online gaming. Zynga's games have been downloaded over 6 billion times globally, reaching audiences in more than 175 countries. Additionally, Zynga has developed a next-generation platform for optimizing programmatic advertising, enhancing its capabilities in the mobile advertising space. As a wholly-owned subsidiary of Take-Two Interactive Software, Zynga continues to innovate and expand its presence in the interactive entertainment industry.

PacBio designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes.

Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases. The company's products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic surgery; for stroke prevention in patients with atrial fibrillation; and for secondary prevention of myocardial infarction and stroke. Its products also include PRT060128, an oral and intravenous ADP receptor antagonist for the treatment of patients with acute coronary syndrome; for the prevention of cardiovascular events in patients undergoing percutaneous coronary intervention; and for secondary prevention of myocardial infarction and stroke. In addition, the company's products include PRT062607, an oral Syk-specific kinase inhibitor for treating chronic inflammatory diseases and Rheumatoid Arthritis (RA) which is used to treat certain cancers including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Portola Pharmaceuticals, Inc. was founded in 2003 and is based in South San Francisco, California.

PacBio designs, develops, and manufactures sequencing systems to resolve genetically complex problems. Its single molecule real-time (SMRT) sequencing technology enables single molecule real-time detection of biological processes.

Portola Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops therapeutics for acute and chronic cardiovascular and autoimmune/inflammatory diseases. The company's products include PRT054021, an oral factor Xa inhibitor for the prevention and treatment of deep vein thrombosis and pulmonary embolism after orthopedic surgery; for stroke prevention in patients with atrial fibrillation; and for secondary prevention of myocardial infarction and stroke. Its products also include PRT060128, an oral and intravenous ADP receptor antagonist for the treatment of patients with acute coronary syndrome; for the prevention of cardiovascular events in patients undergoing percutaneous coronary intervention; and for secondary prevention of myocardial infarction and stroke. In addition, the company's products include PRT062607, an oral Syk-specific kinase inhibitor for treating chronic inflammatory diseases and Rheumatoid Arthritis (RA) which is used to treat certain cancers including non-Hodgkin's lymphoma and chronic lymphocytic leukemia. Portola Pharmaceuticals, Inc. was founded in 2003 and is based in South San Francisco, California.

FibroGen, Inc. is a biopharmaceutical company dedicated to discovering, developing, and commercializing therapeutics to address significant unmet medical needs. The company is advancing Roxadustat, an oral small molecule inhibitor of hypoxia-inducible factor prolyl hydroxylases, which is in Phase III clinical development for treating anemia in chronic kidney disease in the United States and Europe, and in Phase II/III development for anemia associated with myelodysplastic syndromes in China. Additionally, FibroGen is developing Pamrevlumab, a human monoclonal antibody that targets connective tissue growth factor, currently in Phase III trials for idiopathic pulmonary fibrosis, pancreatic cancer, liver fibrosis, and diabetic kidney disease, along with a Phase II trial for Duchenne muscular dystrophy. The company has established collaboration agreements with Astellas Pharma Inc. and AstraZeneca AB. Founded in 1993 and headquartered in San Francisco, California, FibroGen generates most of its revenue through these collaborative partnerships.

Alexza Pharmaceuticals, Inc. is a pharmaceutical company based in Mountain View, California, specializing in the research, development, and commercialization of innovative products for the acute treatment of central nervous system conditions. The company utilizes its proprietary Staccato system, which vaporizes drug formulations into an aerosol for inhalation, allowing for rapid delivery and therapeutic onset. Its primary product, ADASUVE, is an inhalation powder used for the acute treatment of agitation associated with schizophrenia and bipolar I disorder in adults. Additionally, Alexza is developing AZ-002 for acute repetitive seizures and AZ-007 for insomnia, both utilizing the Staccato technology. Founded in 2001, the company has also formed a collaboration with Grupo Ferrer Internacional S.A. In 2016, Alexza became a subsidiary of Ferrer Therapeutics, Inc.